Trials / Unknown
UnknownNCT00154648
CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist
An Open, Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) Study of Arteries Using Gadovist 1.0 in Comparison to Intra-Arterial Digital Subtraction Angiography (IA DSA) Using Ultravist
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced magnetic resonance angiography (CE-MRA) of the arteries.
Detailed description
This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced Magnetic Resonance Angiography (CE-MRA) of arteries (specified vessel segments) by analyzing the rate of agreement, image quality, and diagnostic confidence between a CE-MRA based diagnosis and the diagnosis achieved from the comparator procedure IA DSA using Ultravist.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CE-MRA |
Timeline
- Start date
- 2005-06-01
- First posted
- 2005-09-12
- Last updated
- 2007-06-05
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00154648. Inclusion in this directory is not an endorsement.